Home
>
National Drug Code (NDC)
>
Famvir
Famvir - 0078-0366-15 - (famciclovir)
Drug Information of Famvir
| Product NDC: | 0078-0366 |
| Proprietary Name: | Famvir |
| Non Proprietary Name: | famciclovir |
| Active Ingredient(s): | 125 mg/1 & nbsp; famciclovir |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Famvir
| Product NDC: | 0078-0366 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020363 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19940629 |
Package Information of Famvir
| Package NDC: | 0078-0366-15 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (0078-0366-15) |
NDC Information of Famvir
| NDC Code | 0078-0366-15 |
| Proprietary Name | Famvir |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (0078-0366-15) |
| Product NDC | 0078-0366 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | famciclovir |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19940629 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | FAMCICLOVIR |
| Strength Number | 125 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |
